Skip to main content

Table 2 Death data of participants

From: Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia

Survival status

Total

N = 606

High muscle mass

(AST/ALT)

Low muscle mass

(AST/ALT)

P-value

High muscle mass

(Cr/CysC*100)

Low muscle mass

(Cr/CysC*100)

P-value

1 year, n (%)

< 0.001

 

< 0.001

 survival

339(55.94)

191(63.04)

148(48.84)

 

207(68.09)

132(43.71)

 

 death

267(44.06)

112(36.96)

155(51.16)

 

97(31.91)

170(56.29)

 

2 years, n (%)

0.001

 

< 0.001

 survival

316(52.15)

178(58.75)

138(45.54)

 

196(64.47)

120(39.74)

 

 death

290(47.85)

125(41.25)

165(54.46)

 

108(35.53)

182(60.26)

 

3 years, n (%)

0.003

 

< 0.001

 survival

310(51.16)

173(57.1)

137(45.21)

 

193(63.49)

117(38.74)

 

 death

296(48.84)

130(42.9)

166(54.79)

 

111(36.51)

185(61.26)

 
  1. Note: high muscle mass: AST/ALT≤1.48 or Cr/CysC*100 > 64.64, low muscle mass: AST/ALT> 1.48 or Cr/CysC*100 ≤ 64.64